Delta virus infection and hepatocellular carcinoma
- PMID: 38634678
- DOI: 10.1111/liv.15882
Delta virus infection and hepatocellular carcinoma
References
REFERENCES
-
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209‐249.
-
- Alfaiate D, Clement S, Gomes D, Goosens NF. Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta‐analysis of observational studies. J Hepatol. 2020;73:533‐539.
-
- Roulot D, Brichler S, Layese R, et al. Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta. J Hepatol. 2020;73:1046‐1059.
-
- Giannini E, Pasta A, Pieri G, et al. Liver Int. in press.
-
- Brancaccio G, Coco B, Nardi A, et al. Trends in chronic hepatitis B virus infection in Italy over a 10‐year period: clues from the nationwide PITER and MASTER cohorts toward elimination. Int J Infect Dis. 2023;129:266‐273.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical